Jo Oliver
GlaxoSmithKline
3 Papers
Jo Oliver is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Workgroup & Cytochalasin. The author has an hindex of 3, co-authored 3 publications. Previous affiliations of Jo Oliver include University of Hertfordshire.
Chat about Author
Papers
Mouse lymphoma thymidine kinase gene mutation assay: follow-up International Workshop on Genotoxicity Test Procedures, New Orleans, Louisiana, April 2000.
Martha M. Moore,Masamitsu Honma,Julie Clements,Karen Harrington-Brock,Takumi Awogi,George Bolcsfoldi,Maria A. Cifone,Deborah D. Collard,Michael D. Fellows,Kathryn Flanders,B. Bhaskar Gollapudi,Peter Jenkinson,Paul Kirby,Stephan Kirchner,Joann Kraycer,Stephen McEnaney,Wolfgang Muster,Brian Myhr,Michael R. O’Donovan,Jo Oliver,Marie-Claude Ouldelhkim,Kamala Pant,Robert Preston,Colin Riach,Richard H.C. San,Hiroyasu Shimada,Leon F. Stankowski +26 more
TL;DR: The Mouse Lymphoma Assay Workgroup of the International Workshop on Genotoxicity Test Procedures held a second harmonization meeting just prior to the U.S. Environmental Mutagen Society Meeting in New Orleans, LA, in April 2000 and unanimously agreed that the relative total growth (RTG) should be used as the cytotoxicity measure for concentration selection and data evaluation.
75
Mouse lymphoma thymidine kinase gene mutation assay: International Workshop on Genotoxicity Tests Workgroup report--Plymouth, UK 2002.
Martha M. Moore,Masamitsu Honma,Julie Clements,George Bolcsfoldi,Maria A. Cifone,Robert R. Delongchamp,Michael D. Fellows,B. Bhaskar Gollapudi,Peter Jenkinson,Paul Kirby,Stephan Kirchner,Wolfgang Muster,Brian Myhr,Michael R. O’Donovan,Jo Oliver,Takashi Omori,Marie-Claude Ouldelhkim,Kamala Pant,Robert Preston,Colin Riach,Richard H.C. San,Leon F. Stankowski,Ajit K. Thakur,Shinobu Wakuri,Isao Yoshimura +24 more
TL;DR: A general strategy was developed and the Workgroup members agreed to evaluate this new proposed approach using their own laboratory data, which should lead to a consensus global approach for data evaluation in the near future.
SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study.
Elisabeth Lorge,Véronique Thybaud,Marilyn J. Aardema,Jo Oliver,Akihiro Wakata,Giocondo Lorenzon,Daniel Marzin +6 more
TL;DR: The optimal detection was ensured when a short treatment followed by a long recovery was associated with a long continuous treatment without recovery, and there was no impact of the presence or absence of cytochalasin B on the detection of micronucleated cells on cell lines.